Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 54.30
+0.40 (0.74%)
At close: Feb 11, 2026
Qing Song Health Market Cap
Qing Song Health has a market cap or net worth of 3.59 billion as of February 20, 2026. Its market cap has decreased by -22.72% in one year.
Market Cap
3.59B
Enterprise Value
4.02B
Revenue
1.08B
Ranking
n/a
PE Ratio
53.58
Stock Price
54.30
Market Cap Chart
Since December 27, 2022, Qing Song Health's market cap has increased from 2.32B to 3.59B, an increase of 54.86%. That is a compound annual growth rate of 15.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.59B | -13.67% |
| Dec 31, 2025 | 4.16B | -29.22% |
| Dec 31, 2024 | 5.88B | 28.33% |
| Dec 29, 2023 | 4.58B | 120.52% |
| Dec 30, 2022 | 2.08B | -10.44% |
| Dec 27, 2022 | 2.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Nang Kuang Pharmaceutical | 3.74B |
| BRIM Biotechnology | 3.72B |
| Genovate Biotechnology | 3.64B |
| Merdury Biopharmaceutical | 3.58B |